학술논문

Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors
Document Type
Article
Source
In Annals of Oncology May 2018 29(5):1304-1311
Subject
Language
ISSN
0923-7534